| Primary |
| Hypertension |
39.6% |
| Product Used For Unknown Indication |
21.6% |
| Drug Use For Unknown Indication |
6.6% |
| Diabetes Mellitus |
4.0% |
| Depression |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Hypercholesterolaemia |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Arrhythmia |
2.1% |
| Cardiac Disorder |
2.1% |
| Atrial Fibrillation |
2.0% |
| Angina Pectoris |
1.6% |
| Blood Pressure |
1.6% |
| Anxiety |
1.6% |
| Pain |
1.5% |
| Tachycardia |
1.4% |
| Blood Pressure Abnormal |
1.2% |
| Hypothyroidism |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
| Blood Pressure Increased |
1.1% |
|
| Syncope |
13.7% |
| Completed Suicide |
10.3% |
| Bradycardia |
6.9% |
| Toxicity To Various Agents |
6.8% |
| Vomiting |
5.0% |
| Hypotension |
4.9% |
| Malaise |
4.8% |
| Weight Decreased |
4.6% |
| Weight Increased |
4.6% |
| Palpitations |
4.4% |
| Hypertension |
4.2% |
| Sinus Bradycardia |
3.9% |
| Pharmaceutical Product Complaint |
3.7% |
| Presyncope |
3.7% |
| Blood Pressure Increased |
3.2% |
| Dizziness |
3.2% |
| Drug Ineffective |
3.2% |
| Off Label Use |
3.2% |
| Cerebrovascular Accident |
2.9% |
| Circulatory Collapse |
2.7% |
|
| Secondary |
| Hypertension |
28.1% |
| Product Used For Unknown Indication |
23.8% |
| Drug Use For Unknown Indication |
20.0% |
| Diabetes Mellitus |
3.5% |
| Depression |
3.2% |
| Atrial Fibrillation |
1.9% |
| Arrhythmia |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Anxiety |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Essential Hypertension |
1.5% |
| Pain |
1.4% |
| Cardiac Disorder |
1.4% |
| Blood Pressure |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Hypercholesterolaemia |
1.2% |
| Sleep Disorder |
1.1% |
| Ill-defined Disorder |
1.1% |
| Angina Pectoris |
1.0% |
| Heart Rate Irregular |
1.0% |
|
| Completed Suicide |
18.8% |
| Vomiting |
7.8% |
| Syncope |
7.0% |
| Renal Failure Acute |
6.9% |
| Hypertension |
6.5% |
| Respiratory Arrest |
5.8% |
| Weight Increased |
5.8% |
| Toxicity To Various Agents |
4.4% |
| Off Label Use |
4.0% |
| Hypotension |
3.8% |
| Death |
3.6% |
| Overdose |
3.5% |
| Drug Ineffective |
3.2% |
| Shock |
3.2% |
| Bradycardia |
3.0% |
| Weight Decreased |
2.8% |
| Rash |
2.5% |
| Jaundice |
2.5% |
| Malaise |
2.5% |
| Palpitations |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Hypertension |
18.2% |
| Drug Use For Unknown Indication |
18.2% |
| Rheumatoid Arthritis |
4.7% |
| Pain |
3.7% |
| Diabetes Mellitus |
3.4% |
| Blood Cholesterol Increased |
3.3% |
| Depression |
3.2% |
| Atrial Fibrillation |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Prophylaxis |
1.9% |
| Blood Pressure |
1.9% |
| Osteoporosis |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Cardiac Disorder |
1.8% |
| Anxiety |
1.7% |
| Multiple Myeloma |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Insomnia |
1.2% |
| Arthritis |
1.1% |
|
| Vomiting |
12.7% |
| Weight Decreased |
10.3% |
| Weight Increased |
8.0% |
| Nausea |
5.9% |
| Myocardial Infarction |
5.7% |
| Drug Ineffective |
5.7% |
| Pain |
5.2% |
| Urinary Tract Infection |
4.4% |
| Vision Blurred |
4.2% |
| Renal Failure Acute |
4.1% |
| Rash |
3.9% |
| Pruritus |
3.7% |
| Pain In Extremity |
3.7% |
| Death |
3.6% |
| Tremor |
3.4% |
| Flushing |
3.4% |
| Pneumonia |
3.2% |
| Syncope |
3.1% |
| Somnolence |
3.1% |
| Myalgia |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
30.3% |
| Hypertension |
19.8% |
| Drug Use For Unknown Indication |
13.2% |
| Depression |
7.6% |
| Diabetes Mellitus |
4.9% |
| Cardiac Disorder |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Hypothyroidism |
2.1% |
| Arthritis |
1.9% |
| Blood Pressure |
1.9% |
| Atrial Fibrillation |
1.6% |
| Tachyarrhythmia |
1.6% |
| Urine Abnormality |
1.6% |
| Dyslipidaemia |
1.4% |
| Staphylococcal Infection |
1.4% |
| Erectile Dysfunction |
1.2% |
| Heart Rate |
1.2% |
| Migraine |
1.2% |
| Pain |
1.2% |
| Blood Pressure Abnormal |
1.0% |
|
| Drug Interaction |
19.7% |
| Hypertension |
9.2% |
| Pituitary Tumour Benign |
6.6% |
| Myocardial Infarction |
5.3% |
| Renal Failure Acute |
5.3% |
| Shock |
5.3% |
| Vestibular Disorder |
5.3% |
| Bradycardia |
3.9% |
| Dehydration |
3.9% |
| Loss Of Consciousness |
3.9% |
| Lung Disorder |
3.9% |
| Rash |
3.9% |
| Syncope |
3.9% |
| Weight Increased |
3.9% |
| Drug Hypersensitivity |
2.6% |
| Drug Ineffective |
2.6% |
| Malaise |
2.6% |
| Sinus Bradycardia |
2.6% |
| Therapeutic Response Delayed |
2.6% |
| Tinnitus |
2.6% |
|
